Mohammad Aryaie

Mohammad Aryaie

Auto-generated profile, based on publicly available information

Mohammad Aryaie

Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, UK

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2022 in Journal of Tropical Medicine
Verified
Journal Article
Open access
PDF file
SASima Afrashteh
Sima Afrashteh
MFMohammad Fararouei
Mohammad Fararouei
HGHaleh Ghaem
Haleh Ghaem
MAMohammad Aryaie
Mohammad Aryaie
Despite the recommendation for early diagnosis and rapid initiation of HIV treatment, more than half of patients are in an advanced stage of HIV disease in Iran. This study aimed to investigate the factors related to baseline CD4 cell count and advanced HIV disease (AHD) in Southern Iran. The study comprised all adults between 15 and 87 years of age who were newly diagnosed with HIV in Southern Iran. Linear and logistic regressions were used to identify baseline CD4 cell count predictors and AHD, respectively. A total of 820 (53.9) HIV-infected individuals over 15 years of age were at the AHD stage. Based on the results of the multiple logistic regression, older age at diagnosis (OR≥40/<30=2.68, 95 CI=1.385.19), gender (ORfemale/male=0.62, 95 CI=0.440.85), HIV/TB coinfection (ORyes/no=1.98, 95 CI=1.293.02), HIV/HBV coinfection (ORyes/no=1.58, 95 CI=1.072.38), and hemoglobin (OR=0.89, 95 CI=0.850.92) were directly associated with AHD in HIV/AIDS patients. As suggested by a linear regression model, factors including gender (B Female=44.12, 95 CI:17.86, 70.38), older age (B≥40=111.99, 95 CI:174.70, 49.27), higher education level (B=35.65, 95 CI:5.34, 65.97), WHO clinical stage (BIV=254.53, 95 CI298.82, 210.24), and hemoglobin (B=5.23, 95 CI:0.25, 10.20) were significantly associated with CD4 count.The prevalence of AHD in patients was high in Iran. Our results suggested that several demographic and clinical factors are significantly associated with the baseline CD4 cell count and AHD. Targeted HIV testing, implementation of screening programs for early detection, and access to care services to assure early ART are recommended to improve the clinical status and quality of life of the patients.

25 November 2022 in Surgical Neurology International
Verified
Journal Article
Open access
HKHosseinali Khalili
Hosseinali Khalili
SASaeed Abdollahifard
Saeed Abdollahifard
ANAmin Niakan
Amin Niakan
MAMohammad Aryaie
Mohammad Aryaie
Background: The aim of this study was to assess the effect of Vitamins C and E on mortality, intensive care unit (ICU) length of stay, and Glasgow Outcome Scale-Extended (GOS-E) score of traumatic brain injury (TBI) patients.Methods: Using data from records of patients in a retrospective cohort study, we included 1321 TBI patients, 269 treated and 1052 untreated, aged over 18 years with information on exposure (i.e., Vitamins C and E) and confounders. Age, Glasgow Coma Scale, pupil status, Rotterdam classification, blood sugar, blood pressure, international normalized ratio, and comorbidity of patients were considered as the confounding factors. Endpoints were GOS-E on follow-up, mortality, and ICU length of stay. Propensity score matching was performed to adjust the confounders.Results: Based on the average treatment effect estimates, the use of Vitamins C and E reduced the risk of mortality (risk difference [RD]: −0.07; 95% confidence interval [CI]: −0.14–−0.003) and reduced the length of ICU stay (RD -1.77 95% CI:-3.71-0.16). Furthermore, our results showed that GOS-E was improved significantly (RD: 0.09, 95% CI : 0.03-0.16).Conclusion: Our study suggests that using Vitamins C and E could decrease mortality and length of ICU stay and improve the GOS-E score and functions of the patients with severe TBI. As they are safe and inexpensive medications, they can be used in routine practice in ICUs to improve the outcomes of TBI patients.

12 March 2022 in Epidemiology and Health
Verified
Journal Article
Open access
PDF file
RMReza Mirahmadizadeh
Reza Mirahmadizadeh
MSMohammad Taghi Badeleh Shamooshaki
Mohammad Taghi Badeleh Shamooshaki
ADAmineh Dadvar
Amineh Dadvar
MMMohammad Javad Moradian
Mohammad Javad Moradian
MAMohammad Aryaie
Mohammad Aryaie
OBJECTIVES: Previous studies have estimated the risk of death associated with unemployment in the coronavirus disease 2019 (COVID-19) pandemic, but no studies have examined unemployment before COVID-19 infection as a risk factor for COVID-19-related mortality. Thus, this study aimed to investigate COVID-19 mortality among this population.METHODS: Data on 50,038 people aged 25-59 years were collected from 38 agencies in Fars Province, Iran, from February 2020 to July 2021. Follow-up lasted from participants’ diagnosis with COVID-19 based on the results of a reverse transcription-polymerase chain reaction test to participants’ death or the end of the study period. The association between unemployment and COVID-19-related mortality was estimated using the Poisson regression method, and a sensitivity analysis was conducted to calculate the E-value.RESULTS: Unemployment was associated with a 2.41-fold (95% confidence interval [CI], 2.01 to 2.90) higher age-adjusted and sex-adjusted risk of COVID-19-related mortality. The adjusted Poisson regression analysis showed 8.82 (95% CI, 6.42 to 12.11), 2.84 (95% CI, 1.90 to 4.24), and 1.58 (95% CI, 1.24 to 2.01) times higher risks of COVID-19-related mortality among unemployed people aged 25-39 years, 40-49 years, and 50-59 years, respectively, than among their employed counterparts. Unemployment increased the risk of COVID-19 mortality by 3.31 (95% CI, 2.31 to 4.74) and 2.30 (95% CI, 1.86 to 2.84) times in female and male, respectively. The E-value was 3.43, reflecting the minimum strength of confounding required to shift the association between unemployment and COVID-19-related mortality toward the null.CONCLUSIONS: Unemployment prior to COVID-19 infection increased the risk of COVID-19-related mortality. COVID-19-related mortality disproportionately impacted unemployed women and younger unemployed people.

23 September 2022 in Cancer Prevention Research
Verified
Journal Article
Closed access
PDF file
MMMaryam Marzban
Maryam Marzban
EMElham Mohebbi
Elham Mohebbi
AHAliakbar Haghdoost
Aliakbar Haghdoost
MAMohammad Aryaie
Mohammad Aryaie
MZMohammad Javad Zahedi
Mohammad Javad Zahedi
ATahmad naghibzadeh tahami
ahmad naghibzadeh tahami
Limited evidence is available to acknowledge the association between opium use and liver cancer. In a case–control study, we recruited 117 cases of primary liver cancer (PLC) and 234 age and sex-matched neighborhood controls from 2016 to 2018. We calculated odds ratios (OR) for opium use and 95% confidence intervals (95% CI), using conditional logistic regressions. Compared with non-users the adjusted OR (AOR, 95% CI) for opium use was 6.5 (95% CI, 2.87–13.44). Compared with people who had no history of use, a strong dose–response effect of opium use was observed by amount of use (AOR, 10.70; 95% CI, 3.92–28.70). Cumulative use of opium also indicated that using over 30 gr-year could increase the PLC risk dramatically (AOR, 11.0; 95% CI, 3.83–31.58). Those who used opium for more than 21 years were highly at risk of PLC (AOR, 11.66; 95% CI, 4.43–30.67). The observed associations were significant even among never tobacco smokers (including cigarette and water-pipe smoking). Prevention Relevance: The results of this study indicate that opium use dramatically increased the risk of liver cancer. Because opioids are increasing for medical and non-medical use globally; accordingly, severe health consequences such as liver cancer have to be investigated widely.

1 December 2017 in Journal of Clinical and Basic Research
Verified
Journal Article
Open access
PDF file
MAMohammad Aryaie
Mohammad Aryaie
DBDanial Bagheri
Danial Bagheri
RORahman Berdi Ozouni-Davaji
Rahman Berdi Ozouni-Davaji
SMSima Mostafshar
Sima Mostafshar
EBEftekhar Bolukat
Eftekhar Bolukat
RKReza Khodabakhshi
Reza Khodabakhshi
Introduction: Breast cancer and its treatment have notable adverse effects on patients’ body image, which could result in disability and psychological distress. Therefore, the present study investigated the association of anxiety, depression, and body image disorder with pain-related disability in post-mastectomy female breast cancer patients. Materials and Methods: This cross-sectional ...

1 October 2016 in Internal Medicine Today
Verified
Journal Article
Open access
PDF file
KMK. Mirkarimi
K. Mirkarimi
ACA.R. Charkazi
A.R. Charkazi
MHM.R. Honarvar
M.R. Honarvar
MKM.J. Kabir
M.J. Kabir
RDR. Berdi Ozouni- Davaji
R. Berdi Ozouni- Davaji
MEM. Eri
M. Eri
Medical journal of gonabad university. ofoghedanesh ofogh-e-danesh